De Novo Pyrimidine Synthesis is a Targetable Vulnerability in IDH Mutant Glioma
Diana D. Shi(Harvard University), Samuel K. McBrayer(The University of Texas Southwestern Medical Center), Bofu Huang(Brigham and Women's Hospital), Joseph Buehler(Children's Medical Center), Keith L. Ligon(Brigham and Women's Hospital), Ralph J. DeBerardinis(Children's Medical Center), Daniel P. Cahill(Harvard University), Yu‐Fen Lin(Emory University), Peter Ly(The University of Texas Southwestern Medical Center), Misty S. Martin-Sandoval(Children's Medical Center), Milan R. Savani(Children's Medical Center), Michael M. Levitt(University of North Texas), Thomas P. Mathews(Children's Medical Center), John M. Asara(Beth Israel Deaconess Medical Center), Sabina Signoretti(Brigham and Women's Hospital), Nathalie Y.R. Agar(Texas Endosurgery Institute), Jennifer E. Endress(Harvard University), Lauren C. Gattie(Children's Medical Center), Mark A. Lehrman(The University of Texas Southwestern Medical Center), Rebecca B. Jennings(IHS Markit (United States)), Sylwia A. Stopka(Brigham and Women's Hospital), Harley I. Kornblum(Neurobehavioral Systems), Timothy E. Richardson(Indiana University – Purdue University Indianapolis), Lauren G. Zacharias(Children's Medical Center), Adam C. Wang(Brigham and Women's Hospital), Isaac S. Harris(University of Rochester Medical Center), Andreas Sutter(Bayer (Germany)), Quang‐Dé Nguyen(Dana-Farber Cancer Institute), Michael S. Regan(Brigham and Women's Hospital), Ryan Looper(University of Utah), Januka Khanal(Brigham and Women's Hospital), Dennis M. Bonal(Dana-Farber Cancer Institute), Cylaina Bird(Neurological Surgery), Andreas Janzer(Bayer (Germany)), Kalil G. Abdullah(University of Pittsburgh), Tammie Dang(The University of Texas Southwestern Medical Center), William G. Kaelin(Broad Institute), Sung‐Woo Lee(Chonnam National University Hwasun Hospital), Min Xu(Children's Medical Center), Wenhua Gao(Brigham and Women's Hospital), Tak W. Mak(University Health Network), Michael Jeffers(Sepragen Corporation (United States)), Stefan Gradl(Bayer (Germany))
Cited by 11
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O <sub>2</sub> Sensing
|Science|2001|4.7k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k